Tekla Capital Management LLC Alkermes Plc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 309,613 shares of ALKS stock, worth $9.66 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

309,613

Previous 309,613 -0.0%

Holding current value

$9.66 Million

Previous $8.73 Million 11.03%

% of portfolio

0.38%

Previous 0.33%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$22.0 - $31.87 $2.63 Million - $3.81 Million	119,491 Added 62.85%	309,613 $6.91 Million
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $2.01 Million - $2.44 Million	-87,187 Reduced 31.44%	190,122 $5 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $2.07 Million - $3.1 Million	-96,515 Reduced 25.82%	277,309 $6.45 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $8.74 Million - $12 Million	373,824 New	373,824 $11.5 Million
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $3.19 Million - $4.27 Million	-169,930 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $367,221 - $597,226	-28,118 Reduced 14.2%	169,930 $2.45 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $1.33 Million - $1.71 Million	46,765 Added 30.91%	198,048 $7.23 Million
Q4 2018 Feb 13, 2019	SELL	$27.94 - $44.61 $552,066 - $881,448	-19,759 Reduced 11.55%	151,283 $4.46 Million
Q2 2018 Aug 13, 2018	SELL	$40.56 - $51.36 $1.59 Million - $2.01 Million	-39,140 Reduced 18.62%	171,042 $7.04 Million
Q1 2018 May 14, 2018	BUY	$53.61 - $67.26 $3.54 Million - $4.45 Million	66,110 Added 45.89%	210,182 $12.2 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $6.87 Million - $7.98 Million	144,072	144,072 $7.89 Million

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

180M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.12B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Alkermes Plc. Transaction History